Press release
COLLEEN CRABTREE VOLUNTEERS TO HOST LEUKEMIA AND LYMPHOMA SOCIETY FUNDRAISER
West Hollywood, CA - Comedic actress Colleen Crabtree, star of HBO’s U.S. Comedy Arts Festival winner "Closing Escrow," has volunteered to serve as celebrity “ball-caller” for West Hollywood’s Legendary Bingo fundraiser on October 17, 2007. The event will be held at Hamburger Mary’s, 8288 Santa Monica Blvd., at 9:00 p.m. Proceeds will benefit the Leukemia and Lymphoma Society’s Team In Training.Team In Training (www.teamintraining.org) provides endurance training to run or walk marathons and half marathons or participate in triathlons and century (100-mile) bike rides. In exchange for personalized coaching, participation in training clinics, and travel expenses to events, participants help raise money towards cures for blood cancers such as leukemia, lymphoma, and myeloma.
"I've witnessed the pain and uncertainty of this type of disease through my very close friends," says Crabtree. "I'm extremely honored to represent this cause."
Established in 1998, Legendary Bingo is a weekly fundraiser that has become a West Hollywood cultural landmark. Each week features a different charity. The event is led by actors Jeffrey Bowman ("Bingo-boy") and Scott Presley ("The Fabulous Belle Aire").
Past celebrity ball-callers include Courtney Cox, David Spade, Loni Anderson, and Ruth Buzzi.
###
For more information, or to interview Colleen Crabtree, contact Livia Squires at contact@squirespr.com or call (310) 273-4340.
For more information on Team In Training, visit www.teamintraining.org.
About Colleen Crabtree:
Colleen Crabtree is currently filming “Opposite Day,” in which she leads alongside Pauly Shore. She recently appeared on USA Network’s “Monk.” She began rehearsals this month with her husband, comedian Dan Rothenberg, on their autobiographical play, "Regretrosexual - The Love Story." It opens at the Hudson Guild Theatre in Los Angeles on February 7, 2008.
To view video demos of Colleen Crabtree’s work, visit www.myspace.com/colleencrabtree.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release COLLEEN CRABTREE VOLUNTEERS TO HOST LEUKEMIA AND LYMPHOMA SOCIETY FUNDRAISER here
News-ID: 30593 • Views: …
More Releases from Squires Public Relations for Colleen Crabtree

COLLEEN CRABTREE STARS IN NEW FILM ‘CLOSING ESCROW’
Los Angeles, CA - Actress and comedian Colleen Crabtree will play the role of Mary in Magnolia Pictures’ new comedy, “Closing Escrow.” The film is directed by Armen Kaprelian. It opens Friday, August 24, 2007 at theaters in Los Angeles, San Francisco, Phoenix, Denver, and New York.
“Escrow” is the story of three quirky families seeking to buy their next home. Each has a reason for moving and a reason they…
More Releases for Leukemia
The Impact Of Increasing Leukemia Prevalence On The Leukemia Therapeutics Market …
The Leukemia Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Leukemia Therapeutics Market Size During the Forecast Period?
In recent times, the market size for leukemia therapeutics has seen robust growth. It is projected to increase from $17.57 billion in 2024…
Leukemia Therapeutics Market - Revolutionizing Leukemia Care: Cutting-Edge Thera …
Newark, New Castle, USA: The "Leukemia Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Leukemia Therapeutics Market: https://www.growthplusreports.com/report/leukemia-therapeutics-market/7759
This latest report researches the industry structure, sales, revenue,…
Acute Lymphoblastic Leukemia Therapeutics Market Size, Acute Lymphoblastic Leuke …
Acute Lymphoblastic Leukemia Therapeutics Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Acute Lymphoblastic Leukemia Therapeutics research data, benefit, gross margin,…
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, T …
Orbisreserach.Com Adds “H1 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Market Pipeline Review 2017 Trend Analysis Report Report” To Its Research Database
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2017, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) pipeline landscape.
Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in the blood-forming cells of the…
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical T …
ReportsWorldwide has announced the addition of a new report title Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trials scenario. This report provides top line data relating to…
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Tri …
ReportsWorldwide has announced the addition of a new report title Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials scenario. This report provides top line data relating to…